1997
DOI: 10.1016/s0140-6736(96)09229-x
|View full text |Cite
|
Sign up to set email alerts
|

Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
83
0
3

Year Published

1997
1997
2020
2020

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(87 citation statements)
references
References 25 publications
1
83
0
3
Order By: Relevance
“…Use of aminoglycosides and fluoroquinolones may also stand independently along with presence of chronic ulcers undergoing antibiotic therapy and could promote the acquisition of MRSA by eradicating susceptible microorganisms such as MSSA. 41 Subinhibitory concentrations of ciprofloxacin induced the production of fibronectin-binding proteins and increased the adhesion to fibronectin-coated surfaces in vitro, promoting host colonization. 42 Fluoroquinolones might influence oxacillin resistance by selective inhibition or by killing of the more susceptible subpopulations in heteroresistant S. aureus.…”
Section: Resultsmentioning
confidence: 99%
“…Use of aminoglycosides and fluoroquinolones may also stand independently along with presence of chronic ulcers undergoing antibiotic therapy and could promote the acquisition of MRSA by eradicating susceptible microorganisms such as MSSA. 41 Subinhibitory concentrations of ciprofloxacin induced the production of fibronectin-binding proteins and increased the adhesion to fibronectin-coated surfaces in vitro, promoting host colonization. 42 Fluoroquinolones might influence oxacillin resistance by selective inhibition or by killing of the more susceptible subpopulations in heteroresistant S. aureus.…”
Section: Resultsmentioning
confidence: 99%
“…High concentration of bacteria in one place, probably as a presence of resistant strains of the subpopulation, and sometimes, limited concentration of quinolones, stimulate the emergence of resistant mutants (31). Quinolones affects the activity of DNA gyrase, weakening the bonds of DNA chain, whereas topoisomerase IV separates DNA chains.…”
Section: Re Si Sta Nce T O Qu I Nol One Smentioning
confidence: 99%
“…The change in amino acid sequences, in the corresponding region of the DNA enzyme complex (quinolone resistance determining region, QRDR), reduces the affinity of the quinolones to the target sites. GrlA subunit (ParC) of topoisomerase IV and GyrA subunit of DNA gyrase are considered as the most common sites of the mutations that lead to the emergence of resistance to these drugs (31,32). Sometimes, a single amino acid mutation is sufficient to get a clinical manifestation of the resistance, but for fluoroquinolones the occurrence of additional mutations is necessary.…”
Section: Re Si Sta Nce T O Qu I Nol One Smentioning
confidence: 99%
“…The role of these agents for resistant of S. epidermidis is well recognized, especially with quinolones. 68 SHEA guidelines lay emphasis on good antibiotic stewardship and, specifically, on fluoroquinolone control.…”
Section: Control Of the Use Of Antimicrobial Agentsmentioning
confidence: 99%